Long Noncoding RNA E2F4as Promotes Progression and Predicts Patient Prognosis in Human Ovarian Cancer

被引:6
|
作者
Park, Sun-Ae [1 ]
Kim, Lee Kyung [1 ]
Kim, Young Tae [2 ]
Heo, Tae-Hwe [1 ]
Kim, Hee Jung [1 ]
机构
[1] Catholic Univ Korea, Coll Pharm, Integrated Res Inst Pharmaceut Sci, Lab Pharmacoimmunol, Seoul 03722, South Korea
[2] Yonsei Univ, Inst Womens Life Med Sci, Dept Obstet & Gynecol, Div Gynecol Oncol,Coll Med, Seoul 03722, South Korea
基金
新加坡国家研究基金会;
关键词
ovarian cancer (OC); long noncoding RNAs (lncRNAs); epithelial– mesenchymal transition (EMT); biomarker; MESENCHYMAL TRANSITION; CERVICAL-CANCER; FAMILY; PROLIFERATION; TRANSCRIPTION; RESISTANCE; INVASION; HOTAIR;
D O I
10.3390/cancers12123626
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary LncRNA is a promising biomarker that predicts the prognosis of a variety of cancers, but the important role of E2F4antisense lncRNA in cancer remains unclear. Therefore, we decided to explore the role of E2F4as lncRNA in the blood of an ovarian cancer patient. We found that E2F4as was highly expressed in ovarian cancer patients, and that the higher the expression of E2F4as, the worse the patient's prognosis. In addition, we observed that downregulation of E2F4as in ovarian cancer cells reduced cell proliferation, invasion and migration, decreased expression of EMT-related genes, and increased apoptosis. These findings suggest that E2F4as may be a predictive biomarker in the blood of ovarian cancer patients, and have shown the potential to promote tumor aggression through EMT-related mechanisms. (1) Background: LncRNAs could be a promising biomarker to predict the prognosis of various cancers. The significance of E2F4antisense lncRNA remains unclear in cancer. In this study, we examined the expression level of E2F4as in the serum of ovarian cancer patients and the functional role of E2F4as. (2) Methods: Serum samples were obtained from 108 OC patients and 32 normal patients to measure the expression of E2F4as in the serum. Ovarian cancer cells were used to investigate the role of E2F4as in cell proliferation, invasion, migration and apoptosis, and the expression of E2F4as was knocked down using RNA interference. In addition, E2F4as knockdown cell lines were used in in vivo experiments. (3) Results: The expression of E2F4as was significantly higher in the serum of OC patients than in that of control patients (p < 0.05). The knockdown of E2F4as in ovarian cancer cells led to a decrease in cell proliferation, invasion and migration and an increase in apoptosis. E2F4as knockdown also reduced the expression of epithelium-mesenchymal metastasis (EMT) genes. (4) Conclusion: These findings highlight the clinical significance of E2F4as in predicting the prognosis of OC patients and suggest its potential in promoting tumour aggressiveness by the regulation of EMT-related mechanisms.
引用
收藏
页码:1 / 17
页数:17
相关论文
共 50 条
  • [1] Long non-coding RNA E2F4as promotes tumor progression and predicts patient prognosis in human ovarian cancer
    Park, S-A.
    Kim, L. K.
    Kim, H. J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [2] A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer
    Cheng, Zhongping
    Guo, Jing
    Chen, Li
    Luo, Ning
    Yang, Weihong
    Qu, Xiaoyan
    ONCOTARGET, 2015, 6 (28) : 25381 - 25389
  • [3] Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer
    Peng, Wei
    Wu, Guoqiu
    Fan, Hong
    Wu, Jianzhong
    Feng, Jifeng
    TUMOR BIOLOGY, 2015, 36 (09) : 6751 - 6758
  • [4] Upregulation of long noncoding RNA LOC440040 promotes tumor progression and predicts poor prognosis in patients with prostate cancer
    Zhang, Cheng
    Liu, Chunlin
    Wu, Jie
    Zheng, Yuxiao
    Xu, Haoxiang
    Cheng, Gong
    Hua, Lixin
    ONCOTARGETS AND THERAPY, 2017, 10 : 4945 - 4954
  • [5] Upregulation of long noncoding RNA HOXA-AS3 promotes tumor progression and predicts poor prognosis in glioma
    Wu, Fan
    Zhang, Chuanbao
    Cai, Jinquan
    Yang, Fan
    Liang, Tingyu
    Yan, Xiaoyan
    Wang, Haoyuan
    Wang, Wen
    Chen, Jing
    Jiang, Tao
    ONCOTARGET, 2017, 8 (32) : 53110 - 53123
  • [6] Overexpression of long noncoding RNA HOTTIP promotes tumor invasion and predicts poor prognosis in gastric cancer
    Ye, Heng
    Liu, Kun
    Qian, Keqing
    ONCOTARGETS AND THERAPY, 2016, 9 : 2081 - 2088
  • [7] Long noncoding RNA NBAT-1 suppresses tumorigenesis and predicts favorable prognosis in ovarian cancer
    Yan, Changsheng
    Jiang, Yi
    Wan, Yicong
    Zhang, Lin
    Liu, Jinhui
    Zhou, Shulin
    Cheng, Wenjun
    ONCOTARGETS AND THERAPY, 2017, 10 : 1993 - 2002
  • [8] A long noncoding RNA ATB is involved in the progression and prognosis of esophageal cancer
    Xiao, Wei
    Jiang, Xiaoqin
    Jia, Weiguang
    Lu, Kaijin
    Zhang, Jun
    Dai, Guihong
    Jiang, Lin
    Yu, Hong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (03): : 2445 - 2451
  • [9] Upregulated long noncoding RNA PANDAR predicts an unfavorable prognosis and promotes tumorigenesis in cholangiocarcinoma
    Xu, Yi
    Jiang, Xingming
    Cui, Yunfu
    ONCOTARGETS AND THERAPY, 2017, 10 : 2873 - 2883
  • [10] A specific upregulated long noncoding RNA in colorectal cancer promotes cancer progression
    Li, Junshu
    Ji, Yanhong
    Na Chen
    Wang, Huiling
    Chao Fang
    Yin, Xiaonan
    Jiang, Zhiyuan
    Dong, Zhexu
    Dan Zhu
    Fu, Jiamei
    Zhou, Wencheng
    Jiang, Ruiyi
    Ling He
    Zhang Hantao
    Gang Shi
    Lin Cheng
    Su, Xiaolan
    Lei Dai
    Deng, Hongxin
    JCI INSIGHT, 2022, 7 (15)